Tumor characteristics and survival rate of HER2-low breast cancer patients: a retrospective cohort study

HER2 is an important prognostic marker in breast cancer (BC) patients, which also plays a crucial role in their therapeutic plan. Consequently, a great desire is to thoroughly assess the patients based on their HER2 status. In the current study, we aimed to evaluate HER2-low breast cancer as a new s...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasvandi, Fereshteh, Bayat, Mahdis, Akbari, Atieh, Shojaeian, Fatemeh, Zandi, Ashkan, Rahmani, Jamal, Hashemi, Maryam Omrani, Akbari, Mohammad Esmaeil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550984/
https://www.ncbi.nlm.nih.gov/pubmed/37794050
http://dx.doi.org/10.1038/s41598-023-43186-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550984/
https://www.ncbi.nlm.nih.gov/pubmed/37794050
http://dx.doi.org/10.1038/s41598-023-43186-8

Ejemplares similares